Skip to content

Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07214350
Acronym
SPARC
Enrollment
150
Registered
2025-10-09
Start date
2025-12-02
Completion date
2030-08-31
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Rehabilitation, Heart Disease

Keywords

Physical Activity, Sex Differences

Brief summary

The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during and after they complete cardiac rehabilitation. Participants in this study will have three in-person study visits and may complete two qualitative interviews over a 10-month study period. The greatest risks during the study include physical discomfort, falling, and/or shortness of breath during the fitness testing.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Enrolled in cardiac rehabilitation within the last month * Own a smartphone or tablet for mobile application download

Exclusion criteria

* Planned relocation during the study period out of the local area * Planned medical procedure within the study period that may limit physical activity (i.e., joint replacement) * End-stage kidney disease * Impairment from stroke, injury, or other medical conditions that would prevent participation in or completion of the protocol * Heart transplant * Use of a left ventricular assist device * Pregnant or intending to become pregnant during the study period * Any other illness that, in the opinion of the study physician, would negatively impact or mitigate participation in or completion of the protocol

Design outcomes

Primary

MeasureTime frameDescription
Average Daily Step CountBaseline, 3 months, 9 monthsCalculated as an average of daily steps achieved over the previous week at each timepoint.

Secondary

MeasureTime frameDescription
Average moderate-to-vigorous physical activity minutes per week9 monthsSelf-reported moderate-to-vigorous-intensity physical activity minutes per week using the Paffenbarger Physical Activity Questionnaire.

Countries

United States

Contacts

Primary ContactKatherine A Collins-Bennett, PhD
katherine.collins-bennett@duke.edu919-479-2368
Backup ContactJohanna L. Johnson, MS
johanna.johnson@duke.edu919-660-6766

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026